Filter results
You can narrow down the results using the filters
Application type
Sponsor
- AstraZeneca Pty Ltd (7)
- Novo Nordisk Pharmaceuticals Pty Ltd (7)
- Pfizer Australia Pty Ltd (5)
- Roche Products Pty Ltd (5)
- Eli Lilly Australia Pty Ltd (4)
- Novartis Pharmaceuticals Australia Pty Ltd (4)
- Sanofi-Aventis Australia Pty Ltd (4)
- AbbVie Pty Ltd (3)
- Adjutor Healthcare Pty Ltd (2)
- Amgen Australia Pty Ltd (2)
- Aspen Pharmacare Australia Pty Ltd (2)
- Bayer Australia Ltd (2)
- Boehringer Ingelheim Pty Ltd (2)
- Bristol-Myers Squibb Australia Pty Ltd (2)
- Gilead Sciences Pty Ltd (2)
- GlaxoSmithKline Australia Pty Ltd (2)
- Merck Sharp & Dohme (Australia) Pty Ltd (2)
- Seqirus Pty Ltd (2)
- Servier Laboratories (Aust) Pty Ltd (2)
- Takeda Pharmaceuticals Australia Pty Ltd (2)
- Vertex Pharmaceuticals Australia Pty Ltd (2)
- Accord Healthcare Pty Ltd (1)
- Alexion Pharmaceuticals Australasia Pty Ltd (1)
- Allergan Australia Pty Ltd (1)
- Alnylam Australia Pty Ltd (1)
- A Menarini Australia Pty Ltd (1)
- Apellis Australia Pty Ltd (1)
- Apotex Pty Ltd (1)
- Astellas Pharma Australia Pty Ltd (1)
- Baxter Healthcare Pty Ltd (1)
- BeiGene AUS Pty Ltd (1)
- Biocelect Pty Ltd (1)
- BioMarin Pharmaceutical Australia Pty Ltd (1)
- Cipla Australia Pty Ltd (1)
- CSL Behring Australia Pty Ltd (1)
- Douglas Pharmaceuticals Australia Pty Ltd (1)
- Galderma Australia Pty Ltd (1)
- Gedeon Richter Australia Pty Ltd (1)
- Grand Pacific CRO Australia (1)
- Graythan Regulatory Services Pty Ltd (1)
- Hansa Biopharma (Australia) Pty Ltd (1)
- Interpharma Pty Ltd (1)
- Ipsen Pty Ltd (1)
- Janssen-Cilag Pty Ltd (1)
- Link Medical Products Pty Ltd T/A Link Pharmaceuticals (1)
- Merck Healthcare Pty Ltd (1)
- Merz Australia Pty Ltd (1)
- Moderna Australia Pty Ltd (1)
- PPD Australia Pty Ltd (1)
- Reach Pharmaceuticals Pty Ltd (1)
- Regulatory Approval Services Pty Ltd (1)
- Southern XP IP Pty Ltd (1)
- Specialised Therapeutics Alim Pty Ltd (1)
- Stryker Australia Pty Ltd (1)
- Sun Pharma ANZ Pty Ltd (1)
- Telix Pharmaceuticals (ANZ) Pty Ltd (1)
- Theramex Australia Pty Ltd (1)
- UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia (1)
- Vifor Pharma Pty Ltd (1)
Application types:
- Application type A: applications for a 'new medicine' containing a new active substance (new chemical entity or new biological entity) not currently approved in Australia
- Application type B: applications for a 'new combination', where two or more already approved medicines are combined into a single product
- Application type C: applications for a 'new indication', or additional therapeutic use, for an already approved medicine.
For more information visit Prescription medicines: applications under evaluation.
Search
103 result(s) found, displaying 1 to 25
- May-2023Prescription medicine evaluationABRYSVO Pfizer Australia Pty LtdActive ingredient: recombinant respiratory syncytial virus pre-fusion F protein, water for injections.
- May-2023Prescription medicine evaluationEBGLYSS Eli Lilly Australia Pty LtdActive ingredient: lebrikizumab.
- May-2023Prescription medicine evaluationHEPCLUDEX Gilead Sciences Pty LtdActive ingredient: bulevirtide.
- May-2023Prescription medicine evaluationTALZENNA Pfizer Australia Pty LtdActive ingredient: talazoparib tosilate.
- May-2023Prescription medicine evaluationTRADENAME Novo Nordisk Pharmaceuticals Pty LtdActive ingredient: insulin icodec.
- May-2023Prescription medicine evaluationVOXZOGO BioMarin Pharmaceutical Australia Pty LtdActive ingredient: vosoritide.
- Mar-2023Prescription medicine evaluationBELFIDESS Galderma Australia Pty LtdActive ingredient: relabotulinumtoxinA.
- Mar-2023Prescription medicine evaluationBIMZELX UCB Australia Pty Ltd T/A UCB Pharma Division of UCB AustraliaActive ingredient: bimekizumab.
- Mar-2023Prescription medicine evaluationHEMGENIX CSL Behring Australia Pty LtdActive ingredient: etranacogene dezaparvovec.
- Mar-2023Prescription medicine evaluationLOKELMA AstraZeneca Pty LtdActive ingredient: sodium zirconium cyclosilicate hydrate.
- Mar-2023Prescription medicine evaluationNELARABINE-REACH Reach Pharmaceuticals Pty LtdActive ingredient: nelarabine.
- Mar-2023Prescription medicine evaluationNOVOSEVEN RT Novo Nordisk Pharmaceuticals Pty LtdActive ingredient: Eptacog alfa (activated), histidine.
- Mar-2023Prescription medicine evaluationSAIZEN Merck Healthcare Pty LtdActive ingredient: Somatropin.
- Mar-2023Prescription medicine evaluationSYFOVRE Apellis Australia Pty LtdActive ingredient: pegcetacoplan.
- Mar-2023Prescription medicine evaluationVELSIPITY Pfizer Australia Pty LtdActive ingredient: etrasimod arginine.
- Feb-2023Prescription medicine evaluationIBSUREL Aspen Pharmacare Australia Pty LtdActive ingredient: pinaverium bromide.
- Feb-2023Prescription medicine evaluationOPDIVO Bristol-Myers Squibb Australia Pty LtdActive ingredient: nivolumab.
- Feb-2023Prescription medicine evaluationTRIKAFTA Vertex Pharmaceuticals Australia Pty LtdActive ingredient: elexacaftor, ivacaftor, tezacaftor.
- Feb-2023Prescription medicine evaluationVEOZA Astellas Pharma Australia Pty LtdActive ingredient: fezolinetant.
- Feb-2023Prescription medicine evaluationWINLEVI Sun Pharma ANZ Pty LtdActive ingredient: clascoterone.
- Jan-2023Prescription medicine evaluationADCETRIS Takeda Pharmaceuticals Australia Pty LtdActive ingredient: Brentuximab vedotin.
- Jan-2023Prescription medicine evaluationAREXVY GlaxoSmithKline Australia Pty LtdActive ingredient: recombinant respiratory syncytial virus pre-fusion F protein.
- Jan-2023Prescription medicine evaluationGIVLAARI Alnylam Australia Pty LtdActive ingredient: givosiran sodium.
- Jan-2023Prescription medicine evaluationILLUCCIX 25 MCG KIT FOR RADIOPHARMACEUTICAL PREPARATION Telix Pharmaceuticals (ANZ) Pty LtdActive ingredient: Glu-urea-Lys(ahx)-hbed-CC.
Pages
- Current page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Next page Next ›
- Last page Last »